XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 02, 2021
Sep. 26, 2020
Cash flows from operating activities:    
Net income $ 476,604 $ 303,260
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 21,949 27,715
Deferred income taxes 9,219 1,089
Depreciation 52,760 49,407
Amortization of intangibles 45,166 41,684
Change in operating assets and liabilities:    
Decrease in accounts receivable 23,472 96,955
Increase in inventories (93,878) (8,139)
Increase in other current assets (9,123) (16,776)
Increase in other assets (6,116) (2,612)
(Decrease) increase in accounts payable and other current liabilities (4,768) 46,721
Increase in deferred revenue and customer advances 71,889 32,053
Decrease in other liabilities (57,838) (48,332)
Net cash provided by operating activities 529,336 523,025
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (116,614) (125,340)
Business acquisitions, net of cash acquired 0 (76,664)
Investment in unaffiliated companies (867) (3,850)
Payments for intellectual property licenses (7,000) 0
Purchases of investments (241,230) (22,458)
Maturities and sales of investments 117,283 1,751
Net cash used in investing activities (248,428) (226,561)
Cash flows from financing activities:    
Proceeds from debt issuances 510,000 315,000
Payments on debt (250,000) (425,366)
Payments of debt issuance costs (8,537) 0
Proceeds from stock plans 55,000 28,421
Purchases of treasury shares (492,695) (196,353)
Proceeds from derivative contracts 2,325 10,330
Net cash used in financing activities (183,907) (267,968)
Effect of exchange rate changes on cash and cash equivalents (8,994) 10,723
Increase in cash and cash equivalents 88,007 39,219
Cash and cash equivalents at beginning of period 436,695 335,715
Cash and cash equivalents at end of period $ 524,702 $ 374,934